Pharming Group (OTCMKTS:PHGUF) Stock Price Up 10.6% – What’s Next?

Pharming Group (OTCMKTS:PHGUF)’s share price rose 10.6% on Wednesday . The company traded as high as $0.84 and last traded at $0.84. Approximately 2,000 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 3,244 shares. The stock had previously closed at $0.76.

Pharming Group Price Performance

The company has a market capitalization of $550.63 million, a PE ratio of -42.20 and a beta of 1.11. The company has a current ratio of 3.53, a quick ratio of 2.76 and a debt-to-equity ratio of 0.53. The stock has a fifty day simple moving average of $0.80 and a 200-day simple moving average of $0.81.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.